Page last updated: 2024-11-05

zolpidem and Akinetic-Rigid Variant of Huntington Disease

zolpidem has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kantor, S1
Varga, J1
Morton, AJ1

Other Studies

1 other study available for zolpidem and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease mice.
    Neuropharmacology, 2016, Volume: 105

    Topics: Amitriptyline; Animals; Arousal; Behavior, Animal; Dose-Response Relationship, Drug; Electroencephal

2016